Cargando…

Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling

Metformin (MET) can effectively treat endometrial hyperplasia (EH), and the expression of glucose transporter type 4 insulin-responsive (GLUT4) is closely associated with the development of EH. The present study aimed to verify the effect of MET in functional EH and polycystic ovary syndrome (PCOS)....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Zhao, Yangchun, Chen, Long, Li, Ruilan, Ning, Yumei, Zhu, Xiuzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175273/
https://www.ncbi.nlm.nih.gov/pubmed/35552758
http://dx.doi.org/10.3892/mmr.2022.12734
_version_ 1784722422028566528
author Liu, Jie
Zhao, Yangchun
Chen, Long
Li, Ruilan
Ning, Yumei
Zhu, Xiuzhi
author_facet Liu, Jie
Zhao, Yangchun
Chen, Long
Li, Ruilan
Ning, Yumei
Zhu, Xiuzhi
author_sort Liu, Jie
collection PubMed
description Metformin (MET) can effectively treat endometrial hyperplasia (EH), and the expression of glucose transporter type 4 insulin-responsive (GLUT4) is closely associated with the development of EH. The present study aimed to verify the effect of MET in functional EH and polycystic ovary syndrome (PCOS). H&E staining was performed to analyze the severity of EH, and immunohistochemistry was performed to evaluate the expression of GLUT4 in the endometrium of PCOS rats. Reverse transcription-quantitative PCR was used to calculate the expression of long non-coding (lnc)RNA-maternally expressed gene 3 (MEG3), lncRNA-small nucleolar RNA host gene 20 (SNHG20), GLUT4 mRNA, microRNA (miR)-223 and miR-4486. Sequence analysis and luciferase assays were performed to explore the regulatory relationship among certain lncRNAs, miRNAs and target genes. EH in PCOS rats was efficiently inhibited by MET administration. The increased expression of GLUT4 in PCOS rats was attenuated by MET treatment. Moreover, the expression levels of lncRNA-MEG3 and lncRNA-SNHG20 were significantly inhibited in the endometrium of PCOS rats. MET treatment also showed remarkable efficiency in restoring the expression of lncRNA-MEG3 and lncRNA-SNHG20. Meanwhile, the expression levels of miR-223 and miR-4486 were notably elevated in the endometrium of PCOS rats, while MET treatment reduced the expression of miR-223 and miR-4486 in PCOS rats. Furthermore, a luciferase assay confirmed the inhibitory relationship between miR-223 and lncRNA-MEG3/GLUT4 expression, as well as between miR-4486 and lncRNA-SNHG20/GLUT4 expression. GLUT4 knockdown restored the decreased viability of HCC-94 cells induced by overexpression of lncRNA-MEG3. To conclude, MET exhibited a therapeutic effect in the treatment of EH by modulating the lncRNA-MEG3/miR-223/GLUT4 and lncRNA-SNHG20/miR-4486/GLUT4 signaling pathways. This work provides mechanistic insight into the development of EH.
format Online
Article
Text
id pubmed-9175273
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-91752732022-06-14 Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling Liu, Jie Zhao, Yangchun Chen, Long Li, Ruilan Ning, Yumei Zhu, Xiuzhi Mol Med Rep Articles Metformin (MET) can effectively treat endometrial hyperplasia (EH), and the expression of glucose transporter type 4 insulin-responsive (GLUT4) is closely associated with the development of EH. The present study aimed to verify the effect of MET in functional EH and polycystic ovary syndrome (PCOS). H&E staining was performed to analyze the severity of EH, and immunohistochemistry was performed to evaluate the expression of GLUT4 in the endometrium of PCOS rats. Reverse transcription-quantitative PCR was used to calculate the expression of long non-coding (lnc)RNA-maternally expressed gene 3 (MEG3), lncRNA-small nucleolar RNA host gene 20 (SNHG20), GLUT4 mRNA, microRNA (miR)-223 and miR-4486. Sequence analysis and luciferase assays were performed to explore the regulatory relationship among certain lncRNAs, miRNAs and target genes. EH in PCOS rats was efficiently inhibited by MET administration. The increased expression of GLUT4 in PCOS rats was attenuated by MET treatment. Moreover, the expression levels of lncRNA-MEG3 and lncRNA-SNHG20 were significantly inhibited in the endometrium of PCOS rats. MET treatment also showed remarkable efficiency in restoring the expression of lncRNA-MEG3 and lncRNA-SNHG20. Meanwhile, the expression levels of miR-223 and miR-4486 were notably elevated in the endometrium of PCOS rats, while MET treatment reduced the expression of miR-223 and miR-4486 in PCOS rats. Furthermore, a luciferase assay confirmed the inhibitory relationship between miR-223 and lncRNA-MEG3/GLUT4 expression, as well as between miR-4486 and lncRNA-SNHG20/GLUT4 expression. GLUT4 knockdown restored the decreased viability of HCC-94 cells induced by overexpression of lncRNA-MEG3. To conclude, MET exhibited a therapeutic effect in the treatment of EH by modulating the lncRNA-MEG3/miR-223/GLUT4 and lncRNA-SNHG20/miR-4486/GLUT4 signaling pathways. This work provides mechanistic insight into the development of EH. D.A. Spandidos 2022-05-12 /pmc/articles/PMC9175273/ /pubmed/35552758 http://dx.doi.org/10.3892/mmr.2022.12734 Text en Copyright: © Liu et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Liu, Jie
Zhao, Yangchun
Chen, Long
Li, Ruilan
Ning, Yumei
Zhu, Xiuzhi
Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling
title Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling
title_full Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling
title_fullStr Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling
title_full_unstemmed Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling
title_short Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling
title_sort role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of meg3/mir-223/glut4 and snhg20/mir-4486/glut4 signaling
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175273/
https://www.ncbi.nlm.nih.gov/pubmed/35552758
http://dx.doi.org/10.3892/mmr.2022.12734
work_keys_str_mv AT liujie roleofmetformininfunctionalendometrialhyperplasiaandpolycysticovarysyndromeinvolvestheregulationofmeg3mir223glut4andsnhg20mir4486glut4signaling
AT zhaoyangchun roleofmetformininfunctionalendometrialhyperplasiaandpolycysticovarysyndromeinvolvestheregulationofmeg3mir223glut4andsnhg20mir4486glut4signaling
AT chenlong roleofmetformininfunctionalendometrialhyperplasiaandpolycysticovarysyndromeinvolvestheregulationofmeg3mir223glut4andsnhg20mir4486glut4signaling
AT liruilan roleofmetformininfunctionalendometrialhyperplasiaandpolycysticovarysyndromeinvolvestheregulationofmeg3mir223glut4andsnhg20mir4486glut4signaling
AT ningyumei roleofmetformininfunctionalendometrialhyperplasiaandpolycysticovarysyndromeinvolvestheregulationofmeg3mir223glut4andsnhg20mir4486glut4signaling
AT zhuxiuzhi roleofmetformininfunctionalendometrialhyperplasiaandpolycysticovarysyndromeinvolvestheregulationofmeg3mir223glut4andsnhg20mir4486glut4signaling